Tribenzo [b, f] azepine phosphoramidite ligand as well as preparation method and application thereof

By designing tripheno[b,f] azazophosphamide ligand, the problem of insufficient structure of the existing SPHENOL spirocyclic phosphoramide ligand is solved, and its efficient performance in asymmetric catalysis is achieved, especially High yield and chiral induction effects in various reactions.

CN118994247AActive Publication Date: 2024-11-22ZHEJIANG HUAJI BIOTECH
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411074561.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-07
Publication Date
2024-11-22
Estimated Expiration
2044-08-07

AI Technical Summary

Technical Problem

The existing SPHENOL spirocyclic phosphoramidite ligand lacks N-terminal asymmetric modification and the addition of fused-cyclic aromatic hydrocarbons, which limits its application potential in catalytic reactions.

Method used

A tribenzo[b,f] azazophosphamide ligand was designed, with an asymmetric benzoimidostilbene with an N-terminal structure, and was synthesized by palladium catalytic cross-coupling and nucleophilic substitution reaction, enlarging the metal Coordination ability with ligands and introduction of SPHENOL bisphenol backbone to form a novel ligand with excellent asymmetric catalytic properties.

Benefits of technology

This ligand catalyzes the [4+2] cyclization reaction of indoleynylamine and o-benzophenylborate, acetynylamine [2+2+2] cycloaddition reaction and asymmetric azide-endoyne [ 3+2] cycloaddition reaction exhibits high yield and good chiral induction performance, which expands its application scope in asymmetric catalysis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118994247A_ABST
    Figure CN118994247A_ABST
Patent Text Reader

Abstract

The invention discloses a tribenzo [b, f] azepine phosphoramidite ligand and a preparation method and application thereof, the structural formula of the tribenzo [b, f] azepine phosphoramidite ligand is as shown in formula (I): # imgabs0 #, in the tribenzo [b, f] azepine phosphoramidite ligand, the N-terminal structure is asymmetric benziminostilbene, and the benziminostilbene enables a condensed ring system of the N terminal of the ligand to be larger, a conjugated system and pi electron clouds to be enlarged, so that the structure of the ligand is more stable, and the structure of the ligand is more stable. The coordination ability of the metal and the ligand is improved, a certain steric hindrance effect is achieved, asymmetric reactions are promoted, the application range of the ligand can be widened, and the ligand can be suitable for catalyzing various different asymmetric reactions.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of asymmetric catalysis, and specifically relates to a tribenzo[b,f]azepine phosphoramidite ligand and a preparation method and application thereof. Background Art

[0002] Phosphoramidite It is currently recognized as a very versatile and easily available class of good chiral ligands suitable for asymmetric catalysis. Their modular structure can create a ligand library and help fine-tune specific catalytic reactions. Its molecular structure is characterized by the presence of a coordinating PN bond in the molecule, which can coordinate with many metals to form chiral species, thereby catalyzing asymmetric reactions. It has a wide range of applications and can induce the generation of a variety of chiral environments; and, as the field continues to develop, its monodentate properties are also essential in the combined catalysis using mixed ligands.

[0003] Since Feringa et al. (Angew. Chem., Int. Ed. 1996, 35, 2374.) developed the first chiral phosphoramidite ligand (the ligand is an axially chiral monodentate phosphorus ligand with C2 symmetry derived from BINOL) in 1996, a large number of phosphoramidite ligands derived from the BINOL skeleton have been developed and applied.

[0004] Recently, due to the pioneering contributions of Zhou Qilin et al. and Birman et al. (Tetrahedron: Asymmetry. 1999, 10, 125-131; Tetrahedron: Asymmetry. 2002, 13, 1363-1366; Acc. Chem. Res. 2008, 41, 581-593; Acc. Chem. Res. 2012, 45, 1365-1377.), SPINOL has become another superior chiral framework. Its rigid conformation and chemical robustness are the outstanding features that endow this structure and its variants with crucial asymmetric catalysis. The application of its framework in phosphoramidites has also been effectively developed.

[0005] Although both BINOL and SPINOL are versatile, their properties and catalytic behaviors, including their phosphoramidite derivatives, are sometimes complementary. For example, BINOL-based catalysts sometimes show better catalytic activity, while SPINOL-based catalysts usually show better asymmetric induction ability. Therefore, a dilemma is encountered when synergy cannot be achieved in these two features.

[0006] Recently, Sun Jianwei et al. developed a new structure SPHENOL (J.Am.Chem.Soc.2021,143,12445-12449.), which is a new skeleton that is expected to combine the advantages of both BINOL and SPINOL skeletons. Its application has not been fully developed, so the SPHENOL skeleton can be introduced into phosphoramidite.

[0007] So far, the molecular skeleton of phosphoramidite ligand has undergone changes from BINOL, SPINOL, TADDOL to today's SPHENOL:

[0008]

[0009] Compared with the first three well-developed phosphoramidite skeletons, phosphoramidite ligands with the fourth skeleton (i.e., SPHENOL bisphenol skeleton) still have a large room for development. However, the existing SPHENOL spirocyclic phosphoramidite ligands have the following shortcomings: (1) Most of the modifications to SPHENOL spirocyclic phosphoramidite ligands are still limited to the chiral control end of bisphenol, while the modifications to the aromatic ring at the N-terminus have not yet involved the modification of adding condensed aromatic hydrocarbons; (2) The N-terminus of SPHENOL spirocyclic phosphoramidite ligands are basically symmetrical structures, and asymmetric structures are relatively rare. Summary of the invention

[0010] The purpose of the present invention is to provide a tribenzo[b,f]azepine phosphoramidite ligand and a preparation method and application thereof. The tribenzo[b,f]azepine phosphoramidite ligand has a novel structure and has excellent asymmetric catalytic performance and chiral induction performance.

[0011] In order to achieve the above-mentioned object of the invention, the technical solution of the present invention is as follows:

[0012] The tribenzo[b,f]azepine phosphoramidite ligand has a structural formula as shown in formula (I):

[0013]

[0014] In the tribenzo[b,f]azepine phosphoramidite ligand of the present invention, the N-terminal structure is an asymmetric benzoimidostilbene, which makes the condensed ring system at the N-terminal of the ligand larger, and the conjugated system and the π electron cloud are expanded, which not only increases the coordination ability of the metal and the ligand, but also has a certain steric hindrance, which not only helps to promote the occurrence of asymmetric reactions, but also can expand the application scope of the ligand, so that the ligand can be suitable for catalyzing a variety of different asymmetric reactions.

[0015] The present invention also provides a method for preparing the above-mentioned tribenzo[b,f]azepine phosphoramidite ligand, which comprises the following steps:

[0016] (1) Benzoimidostilbene is synthesized by using 1-iodonaphthalene and o-bromoaniline as raw materials through a palladium-catalyzed cross-coupling reaction under an inert atmosphere;

[0017] Wherein, the reaction system of step (1) further comprises a base, a solvent catalyst and an additive, wherein the catalyst comprises palladium acetate, the base comprises cesium carbonate, and the additive comprises triphenylphosphine;

[0018] In the reaction system, the equivalent ratio of 1-iodonaphthalene, o-bromoaniline, norbornene and cesium carbonate is 1:1:2:2, the content of triphenylphosphine is 8-10 mol%, and the content of palladium acetate is 4 mol%;

[0019] The solvent includes dichloromethane or tetrahydrofuran;

[0020] React at 120-150°C for 45-55h;

[0021] (2) under an inert atmosphere, using benzoimidostilbene, a phosphorus donor and a SPHENOL bisphenol skeleton as raw materials, synthesizing the tribenzo[b,f]azepine phosphoramidite ligand through a nucleophilic substitution reaction;

[0022] Specifically, step (2) includes:

[0023] (a) mixing a base, a solvent and a phosphorus donor, and mixing them in an ice bath to obtain a solution A;

[0024] The base is used to remove hydrogen from the benzoiminostilbene, so any base including triethylamine can be applied to the present invention as long as it does not react with the substrate; the phosphorus donor includes phosphorus trichloride, which is used to accept the attack of the iminostilbene N anion to form an intermediate with an NP bond;

[0025] The solvent includes ultra-dry dichloromethane, tetrahydrofuran or other solvents that do not affect the reaction;

[0026] The equivalent ratio of triethylamine to SPHENOL bisphenol skeleton is (6-10):1, more preferably 8:1; the equivalent ratio of phosphorus trichloride to SPHENOL bisphenol skeleton is (1-2.5):1, more preferably 1.5:1;

[0027] (b) under an inert atmosphere, adding benzoimidostilbene to solution A, mixing in an ice bath, and stirring at 25-55° C. (more preferably 40-50° C.) overnight to obtain solution B;

[0028] Wherein, the equivalent ratio of benzoimidostilbene to SPHENOL bisphenol skeleton is (1-3):1, more preferably 1.5:1;

[0029] (c) Under an inert atmosphere, add the SPHENOL bisphenol skeleton to solution B, first react in an ice bath for 3-15 minutes (more preferably 3-5 minutes), and then react at room temperature for 4-5 hours to obtain the tribenzo[b,f]azepine phosphoramidite ligand.

[0030] The present invention also provides the use of the above-mentioned tribenzo[b,f]azepine phosphoramidite ligand in catalyzing the [4+2] cyclization reaction of indole alkynamine and o-benzene cyanophenyl borate; and, preferably, the content of the tribenzo[b,f]azepine phosphoramidite ligand in the reaction system is 10 mol%.

[0031] Under the catalysis of tribenzo[b,f]azepine phosphoramidite ligand and rhodium, the yield of the target product methyl1-(3-amino-2-phenylnaphthalen-1-yl)-1H-indole-2-carboxylate reached 58% and the ee value reached 60%, indicating that tribenzo[b,f]azepine phosphoramidite ligand can effectively catalyze the reaction and induce the formation of axial chirality.

[0032] The present invention also provides the use of the above-mentioned tribenzo[b,f]azepine phosphoramidite ligand in catalyzing the [2+2+2] cycloaddition reaction of alkynamine; and, preferably, the content of the tribenzo[b,f]azepine phosphoramidite ligand in the reaction system is 5 mol%.

[0033] Under the catalysis of tribenzo[b,f]azepine phosphoramidite ligand and iridium, the yield of the target product naphthalen-1-yl1-(4,7-dimethyl-6-phenyl-2-tosylisoindolin-5-yl)-1H-indole-2-carboxylate reached 71% and the ee value reached 72%, indicating that tribenzo[b,f]azepine phosphoramidite ligand can effectively catalyze the reaction and has good chiral induction effect.

[0034] The present invention also provides the use of the above-mentioned tribenzo[b,f]azepine phosphoramidite ligand in catalyzing an asymmetric azide-internal alkyne [3+2] cycloaddition reaction; and, preferably, the content of the tribenzo[b,f]azepine phosphoramidite ligand in the reaction system is 5 mol%.

[0035] Under the catalysis of tribenzo[b,f]azepine phosphoramidite ligand and rhodium, the yield of the target product 1-(1-(naphthalen-1-ylmethyl)-4-phenyl-1H-1,2,3-triazol-5-yl)naphthalen-2-ol reached 73%, and the ee value reached 53%, indicating that tribenzo[b,f]azepine phosphoramidite ligand can effectively catalyze the reaction and has a certain chiral regulation ability.

[0036] Compared with the prior art, the beneficial effects of the present invention are as follows:

[0037] In the tribenzo[b,f]azepine phosphoramidite ligand of the present invention, the N-terminal structure is an asymmetric benzoimidostilbene, which makes the condensed ring system at the N-terminal of the ligand larger, and the conjugated system and the π electron cloud are expanded, which not only increases the coordination ability of the metal and the ligand, but also has a certain steric hindrance, which not only helps to promote the occurrence of asymmetric reactions, but also can expand the scope of application of the ligand, so that the ligand can be used to catalyze a variety of different asymmetric reactions, including but not limited to the [4+2] cyclization reaction of indole alkynamine and o-benzene cyanophenyl borate, the [2+2+2] cycloaddition reaction of alkynamine, and the asymmetric azide-internal alkyne [3+2] cycloaddition reaction. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] Figure 1 The synthetic route of the tribenzo[b,f]azepine phosphoramidite ligand of the present invention is as follows;

[0039] Wherein, equiv means equivalent, PCl3 means phosphorus trichloride, NRt3 means triethylamine, DCM(dry) means dichloromethane (ultra-dry), rt means room temperature, and yield means yield; the same below;

[0040] Figure 2 The synthetic route of benzoimidostilbene is shown in FIG.

[0041] Figure 3 This is the NMR analysis spectrum of benzoiminostilbene;

[0042] Figure 4 is the nuclear magnetic analysis spectrum of the tribenzo[b,f]azepine phosphoramidite ligand of the present invention;

[0043] Figure 5 The reaction scheme for the rhodium-catalyzed [4+2] cyclization of indole acetylamines and o-benzylcyanophenylboronic acid esters is shown;

[0044] Among them, Catalyst means catalyst, Ligand means ligand, and Solvent means solvent;

[0045] Figure 6The reaction scheme for the iridium-catalyzed [2+2+2] cycloaddition of alkynylamines;

[0046] Wherein, [Ir(COD)Cl]2 represents COD iridium chloride dimer, Zn(OTf)2 represents zinc trifluoromethanesulfonate, and toluene represents toluene;

[0047] Figure 7 The reaction scheme for the rhodium-catalyzed asymmetric azide-internal alkyne [3+2] cycloaddition reaction;

[0048] Wherein, [Rh(COD)Cl]2 represents COD rhodium chloride dimer, Represents 0.4 nanometer molecular sieve. DETAILED DESCRIPTION

[0049] The technical solution of the present invention is further described in detail below in conjunction with the accompanying drawings and specific implementation methods.

[0050] Example 1 Synthesis of tribenzo[b,f]azepine phosphoramidite ligand

[0051] The tribenzo[b,f]azepine phosphoramidite ligand of this embodiment has a structural formula as shown in formula (I):

[0052]

[0053] The preparation method of the tribenzo[b,f]azepine phosphoramidite ligand (reaction route see Figure 1 ) comprises the following steps:

[0054] (1) Benzoimidostilbene was synthesized by palladium-catalyzed cross-coupling reaction with 1-iodonaphthalene and o-bromoaniline under inert atmosphere (synthetic route is shown in Figure 2 );

[0055] Specifically, take a sealed tube, fill and discharge nitrogen three times, and in a nitrogen atmosphere, press the preset amount (see Figure 2 ) triphenylphosphine, palladium acetate and cesium carbonate, 1-iodonaphthalene, o-bromoaniline, norbornene were added in sequence, and then ultra-dry DMF was added, and the mixture was reacted at 130°C for 48 hours; the reaction was monitored by spot plate. After the reaction was completed, the mixture was cooled to room temperature, diluted and filtered with ethyl acetate, extracted with water for 3 times, dried over anhydrous MgSO4, and the solvent was removed by rotary evaporator. The mixture was purified by column with petroleum ether: ethyl acetate = 30-20:1 to obtain benzoimidostilbene.

[0056] The obtained benzoimidostilbene was subjected to NMR analysis, and the results were as follows: Figure 3 As shown, the results of NMR analysis are:

[0057] 1H NMR (400MHz, CDCl3) δ7.92(d,J=8.6Hz,1H),7.69(d,J=8.2Hz,1H),7.63(d,J=8.8Hz,1H),7.48-7.42(m,1H),7.37-7.31(m,1H),7.21(d,J=11 .8Hz,1H),7.13-7.07(m,1H),6.99(d,J=7.4Hz,1H),6.96-6.90(m,1H),6.84(d,J=8.6Hz,1H),6.79(d,J=11.4Hz,1H),6.64(d,J=7.8Hz,1H);

[0058] HRMS (ESI, m / z) calculation for C 18 H 13 NNa[M+Na]+:266.0940,found:266.0942.

[0059] (2) Under an inert atmosphere, the tribenzo[b,f]azepine phosphoramidite ligand of this embodiment is synthesized by nucleophilic substitution reaction using benzoimidostilbene, a phosphorus donor and a SPHENOL bisphenol skeleton as raw materials;

[0060] Specifically, it includes:

[0061] (a) under an inert atmosphere, triethylamine, ultra-dry grade dichloromethane and phosphorus trichloride are mixed and mixed in an ice bath to obtain a solution A;

[0062] Specifically, first take a sealed tube and several syringes, put them in an oven, inflate a balloon, take out ice for later use, and set the temperature of the stirring heater to 45°C; take out the sealed tube when it is very hot, screw on the lid immediately, and do not need to be completely sealed, then use a vacuum pump to pump, wait for cooling, adjust the double-row nitrogen, and after the sealed tube is cooled, fill and discharge nitrogen three or four times, and then let the sealed tube be in a nitrogen atmosphere; then take the baked syringe and needle, first exhaust the air and pump out nitrogen three times, and extract triethylamine (8 equivalents); in a nitrogen atmosphere, carefully open the sealed tube lid and inject triethylamine, and in the same operation, take dichloromethane (ultra-dry) (5mmol / 20ml) and add it to the sealed tube, and then put the sealed tube in an ice water bath, and in the same way, take phosphorus trichloride (1.5 equivalents) and add it to the sealed tube, and then cover the lid, turn off the nitrogen, and stir in an ice bath for 15 minutes to obtain solution A;

[0063] (b) under an inert atmosphere, adding benzoimidostilbene to solution A, mixing in an ice bath, and stirring at 45° C. overnight to obtain solution B;

[0064] Specifically, benzoimidostilbene (1.5 equivalents) was weighed, added to a sealed tube under a nitrogen atmosphere, placed in an ice bath for 3 min, and then stirred at 45° C. overnight to obtain solution B;

[0065] (c) under an inert atmosphere, add the SPHENOL bisphenol skeleton to solution B, react in an ice bath for 5 min, and then react at room temperature for 4-5 h to obtain the tribenzo[b,f]azepine phosphoramidite ligand of this example;

[0066] Specifically, under a nitrogen atmosphere, SPHENOL bisphenol skeleton (1 equivalent) was weighed and added to a sealed tube, and the tube was taken out after reacting in an ice bath for 5 minutes. The reaction was basically completed after continuing to react at room temperature for 4 to 5 hours. After the reaction was completed, silica gel powder was added, and after being spin-dried, the column was passed with a developing agent of petroleum ether: ethyl acetate = 50 to 20:1 to obtain a tribenzo[b,f]azepine phosphoramidite ligand.

[0067] The obtained tribenzo[b,f]azepine phosphoramidite ligand was analyzed by NMR and high-resolution mass spectrometry. Figure 4 As shown, the analysis results are:

[0068] 1 H NMR (400MHz, CDCl3) δ8.09 (d, J = 9.2Hz, 1H), 7.84-7.58 (m, 5H), 7.57-7.42 (m, 4H), 7.42-7.32 (m, 3H), 7.30-7.27 (m, 1H), 7.25-7.13 (m, 5 H),7.12-7.04(m,1H),7.04-6.97(m,1H),6.86-5.81(m,1H),3.51-3.21(m,2H),3.13-2.93(m,2H),2.46-2.08(m,2H),2.05-1.88(m,2H).

[0069] HRMS (ESI, m / z) calculation for C 40 H 30 NNaO2P[M+Na] + :623.2014,found:623.2011.

[0070] Example 2 Application of tribenzo[b,f]azepine phosphoramidite ligand in catalyzing the [4+2] cyclization reaction of indole alkynamine and o-benzene cyanophenyl borate

[0071] The reaction scheme for the rhodium-catalyzed [4+2] cyclization of indole acetylamines and o-benzyl cyanophenyl borate is shown in Figure 5It can be seen that in this embodiment, the amount of each raw material is: indole alkynamine (1a) 0.05mmol, o-benzene cyanophenyl borate (2a) 0.1mmol (2 equivalents), catalyst (catalyst) 4mol%, ligand 10mol%, potassium carbonate solvent 0.1mmol (2 equivalents), solvent (solvent, tetrahydrofuran) 1mL; before adding 1a and 2a to the reaction system, the catalyst and ligand are mixed and stirred for 40min. In this embodiment, different ligands are added to the reaction system. Under different ligands and corresponding reaction conditions, the yield (measured by 1H NMR with 1,3,5-trimethoxybenzene as internal standard) and ee value (measured by chiral high performance liquid chromatography) of the target product (3a) are shown in Table 1.

[0072] Table 1

[0073]

[0074]

[0075]

[0076] As can be seen from Table 1, when the tribenzo[b,f]azepine phosphoramidite ligand (i.e., L8) is used in the rhodium-catalyzed [4+2] cyclization reaction of indole acetylamine and o-benzene cyanophenyl borate, it can effectively induce the formation of axial chirality, and the yield of the target product reaches 58% and the ee value reaches 60%.

[0077] Example 3 Application of tribenzo[b,f]azepine phosphoramidite ligand in catalyzing the [2+2+2] cycloaddition reaction of alkynylamine

[0078] The reaction route of the iridium-catalyzed [2+2+2] cycloaddition of alkynylamines is as follows: Figure 6 As shown, this reaction is a reaction known to those skilled in the art. The reaction conditions of this embodiment remain unchanged, and only tribenzo[b,f]azepine phosphoramidite ligand is used as the ligand.

[0079] Depend on Figure 6 It can be seen that with the participation of tribenzo[b,f]azepine phosphoramidite ligand, the yield of the target product naphthalen-1-yl1-(4,7-dimethyl-6-phenyl-2-tosylisoindolin-5-yl)-1H-indole-2-carboxylate reached 71%, and the ee value reached 72%, indicating that tribenzo[b,f]azepine phosphoramidite ligand can also play a good chiral induction role in the iridium-catalyzed alkynamine [2+2+2] cycloaddition reaction.

[0080] Example 4 Application of tribenzo[b,f]azepine phosphoramidite ligand in catalyzing asymmetric azide-internal alkyne [3+2] cycloaddition reaction

[0081] The reaction route of the rhodium-catalyzed asymmetric azide-alkyne [3+2] cycloaddition reaction is as follows Figure 7 As shown, this reaction is a reaction known to those skilled in the art. The reaction conditions of this embodiment remain unchanged, and only tribenzo[b,f]azepine phosphoramidite ligand is used as the ligand.

[0082] Depend on Figure 7 It can be seen that with the participation of the tribenzo[b,f]azepine phosphoramidite ligand, the yield of the target product 1-(1-(naphthalen-1-ylmethyl)-4-phenyl-1H-1,2,3-triazol-5-yl)naphthalen-2-ol reached 73%, and the ee value reached 53%, indicating that the tribenzo[b,f]azepine phosphoramidite ligand also has a certain chiral regulation ability in the rhodium-catalyzed asymmetric azide-internal alkyne [3+2] cycloaddition reaction.

Claims

1. Tribenzo[b,f]azepine phosphoramidite ligand, It is characterized in that The structural formula is shown in formula (I):

2. The method for preparing the tribenzo[b,f]azepine phosphoramidite ligand according to claim 1, It is characterized in that The following steps are involved: (1) Under an inert atmosphere, 1-iodonaphthalene, norbornene and o-bromoaniline are used as raw materials to synthesize benzoimidostilbene through a cross-coupling reaction; (2) Under an inert atmosphere, the tribenzo[b,f]azepine phosphoramidite ligand is synthesized by a nucleophilic substitution reaction using benzoimidostilbene, a phosphorus donor and a SPHENOL bisphenol skeleton as raw materials.

3. The method for preparing the tribenzo[b,f]azepine phosphoramidite ligand according to claim 2, It is characterized in that The reaction system of step (1) further comprises a base, a solvent catalyst and an additive, wherein the catalyst comprises palladium acetate, the base comprises cesium carbonate, and the additive comprises triphenylphosphine; In the reaction system, the equivalent ratio of 1-iodonaphthalene, o-bromoaniline, norbornene and cesium carbonate is 1:1:2:2, the content of triphenylphosphine is 8-10 mol%, and the content of palladium acetate is 4 mol%; The solvent includes dichloromethane or tetrahydrofuran; React at 120-150°C for 45-55h.

4. The method for preparing the tribenzo[b,f]azepine phosphoramidite ligand according to claim 2, It is characterized in that Step (2) comprises: (a) mixing a base, a solvent and a phosphorus donor, and mixing them in an ice bath to obtain a solution A; (b) under an inert atmosphere, adding benzoimidostilbene to solution A, mixing in an ice bath, and stirring at 25-55° C. overnight to obtain solution B; (c) Under an inert atmosphere, add the SPHENOL bisphenol skeleton to solution B, first react in an ice bath for 3-15 minutes, and then react at room temperature for 4-5 hours to obtain the tribenzo[b,f]azepine phosphoramidite ligand.

5. The preparation method according to claim 4, It is characterized in that In step (a), the base comprises triethylamine, the phosphorus donor comprises phosphorus trichloride, and the solvent comprises ultra-dry grade dichloromethane or tetrahydrofuran; The equivalent ratio of triethylamine to SPHENOL bisphenol skeleton is (6-10):1; the equivalent ratio of phosphorus trichloride to SPHENOL bisphenol skeleton is (1-2.5):1; In step (b), the equivalent ratio of benzoimidostilbene to SPHENOL bisphenol skeleton is (1-3):

1.

6. Use of the tribenzo[b,f]azepine phosphoramidite ligand as claimed in claim 1 in catalyzing the [4+2] cyclization reaction of indole alkynamine and o-benzylcyanophenyl borate.

7. The use according to claim 6, It is characterized in that In the reaction system, the content of the tribenzo[b,f]azepine phosphoramidite ligand is 10 mol%.

8. Use of the tribenzo[b,f]azepine phosphoramidite ligand as claimed in claim 1 in catalyzing the [2+2+2] cycloaddition reaction of alkynylamines.

9. Use of the tribenzo[b,f]azepine phosphoramidite ligand as claimed in claim 1 in catalyzing an asymmetric azide-internal alkyne [3+2] cycloaddition reaction.

10. The use according to claim 8 or 9, It is characterized in that In the reaction system, the content of the tribenzo[b,f]azepine phosphoramidite ligand is 5 mol%.

Citation Information

Patent Citations

  • Chiral spiro compound and preparation method and application thereof

    CN113527066A

  • Axial chiral 1, 2, 3-triazole compound as well as preparation method and application thereof

    CN114957140A

  • Chiral spiro compound as well as preparation method and application thereof

    CN115353529A

  • 3, 3 '-dimethyl substituted chiral spiro diphenol compound and preparation method thereof

    CN115611716A

  • Axial chiral Click synthesis method for heterogeneous catalysis of alkyne and azide

    CN116217320A